Evaluation of CT Perfusion Parameters as a Potential Biomarker for Treatment Response in Pancreatic Cancer
Ages Eligible for Study: 18 Years and older (Adult, Senior)
Sexes Eligible for Study: All
- Signed informed consent form
- Histologically or cytologically confirmed pancreatic ductal adenocarcinoma
Other eligibility criteria may apply.
- Patients unable to provide informed consent
- Women who are pregnant or intending to become pregnant during the study
- Patients with body mass index greater than 40 kg/m^2
- History of severe allergic-like reaction to iodinated contrast media
Other exclusion criteria may apply.